NYSE • Healthcare • Drug Manufacturers - Specialty & Generic • IN • USD
Dr. Reddy's Laboratories Limited (RDY) has a consensus analyst rating of Buy, based on 12 analysts covering the stock. Of those, 6 recommend buying, 4 recommend holding, and 2 recommend selling.
No price target data available.
Be the first to know when stocks drop below their intrinsic value.
